104 / 464
SUNDAY 7 MAY 2017
104
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
08:45 > RTTs skills for proton therapy – how and what to include in a learning
programme
Speaker: A. Boejen (Denmark)
SP-0215
09:10 > How to start up a proton therapy department – the point of view of a
RTT
Speaker: M. Furberg (Sweden)
SP-0216
09:35 > Workflow in a proton therapy department – real difference from photon
therapy?
Speaker: F. Fellin (Italy)
SP-0217
SYMPOSIUMWITH PROFFERED PAPERS
Combining tumour and normal tissue models
08:45 - 10:00 | LEHAR 4
In this session, A. Kiltie will show that in the process of assessment of the efficacy of
drugs as radio sensitising agents, it is important to determine their effects on normal
tissues as well as tumours. She will show how her group developed a modified
crypt assay to assess acute toxicity on bowel surrounding the bladder and have
developed a method using the small animal radiation research platform to assess
late bowel toxicity. E. Deutsch will give examples of clinical failures, that were partly
due to inappropriate preclinical modelling. He will show how the modelling of the
differential index is challenging because of its organ specific nature and kinetics and,
will discuss possible integration of the immune component of normal tissue response
into the models.
Chair: M. Vozenin (Switzerland)
Co-chair: M. Nevinny (Austria)
08:45 > Novel approaches in the study of bladder cancer
A. Kiltie (UK)
SP-0218
09:07 > Optimising the output of preclinical lung models to optimize the
chances of success into the clinic.
E. Deutsch (France)
SP-0219
09:29 > Exploiting novel combined-modality approaches for treatment of highly
aggressive pancreas carcinomas
M. Orth (Germany), L. Posselt, S. Kirchleitner, J. Schuster, C. Belka,
M. Schnurr, K. Lauber
OC-0220
09:39 > High performance radiosensitivity assay to predict post radiation
overreactions
G. Vogin (France), L. Bodgi, A. Canet, S. Pereira, J. Gillet-Daubin, N. Foray
OC-0221
09:49 > GnRH receptor blockade reduces radiation-induced bladder toxicity:
first evidence in a rat model.